GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
USLYX
Price
$70.09
Change
-$1.18 (-1.66%)
Updated
Feb 21 closing price
Net Assets
2.22B
Ad is loading...

GFACX vs USLYX

Header iconGFACX vs USLYX Comparison
Open Charts GFACX vs USLYXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
JHancock U.S. Global Leaders Growth R2
Price$70.09
Change-$1.18 (-1.66%)
VolumeN/A
Net Assets2.22B
GFACX vs USLYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. USLYX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and USLYX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. USLYX (2.22B). GFACX (0.00) and USLYX (0.00) have matching dividends . GFACX was incepted earlier than USLYX: GFACX (24 years) vs USLYX (13 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. USLYX (24.00). USLYX has a lower initial minimum investment than GFACX: USLYX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. USLYX (-3.19). GFACX return over 5 years is better than : 32.83 vs. USLYX (20.37).
GFACXUSLYXGFACX / USLYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years13 years-
Gain YTD2.9802.053145%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets304B2.22B13,688%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.15-3.19-318%
Returns for 3 years17.6912.70139%
Returns for 5 years32.8320.37161%
Returns for 10 years55.6360.2892%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding